Sweden
· Delayed Price · Currency is SEK CS Medica Statistics
Total Valuation
CS Medica has a market cap or net worth of SEK 15.67 million.
| Market Cap | 15.67M |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Friday, January 10, 2025.
| Earnings Date | Jan 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CS Medica has 13.81 million shares outstanding. The number of shares has increased by 38.98% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 13.81M |
| Shares Change (YoY) | +38.98% |
| Shares Change (QoQ) | +38.98% |
| Owned by Insiders (%) | 58.91% |
| Owned by Institutions (%) | n/a |
| Float | 5.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| PB Ratio | 2.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.30, with a Debt / Equity ratio of 2.19.
| Current Ratio | 0.30 |
| Quick Ratio | 0.24 |
| Debt / Equity | 2.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.18 |
Financial Efficiency
Return on equity (ROE) is -117.48% and return on invested capital (ROIC) is -40.64%.
| Return on Equity (ROE) | -117.48% |
| Return on Assets (ROA) | -25.08% |
| Return on Capital (ROIC) | -40.64% |
| Revenue Per Employee | 1.43M |
| Profits Per Employee | -1.63M |
| Employee Count | 9 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -68.29% |
| 50-Day Moving Average | 6.54 |
| 200-Day Moving Average | 7.77 |
| Relative Strength Index (RSI) | 20.71 |
| Average Volume (20 Days) | 235,418 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CS Medica had revenue of SEK 12.84 million and -14.64 million in losses. Loss per share was -0.85.
| Revenue | 12.84M |
| Gross Profit | 4.87M |
| Operating Income | -18.94M |
| Pretax Income | -21.95M |
| Net Income | -14.64M |
| EBITDA | -15.73M |
| EBIT | -18.94M |
| Loss Per Share | -0.85 |
Balance Sheet
The company has 26,865 in cash and 20.01 million in debt, giving a net cash position of -19.98 million or -1.45 per share.
| Cash & Cash Equivalents | 26,865 |
| Total Debt | 20.01M |
| Net Cash | -19.98M |
| Net Cash Per Share | -1.45 |
| Equity (Book Value) | 9.13M |
| Book Value Per Share | 0.53 |
| Working Capital | -18.00M |
Cash Flow
| Operating Cash Flow | -6.60M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 37.92%, with operating and profit margins of -147.55% and -114.06%.
| Gross Margin | 37.92% |
| Operating Margin | -147.55% |
| Pretax Margin | -171.01% |
| Profit Margin | -114.06% |
| EBITDA Margin | -122.55% |
| EBIT Margin | -147.55% |
| FCF Margin | n/a |
Dividends & Yields
CS Medica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.98% |
| Shareholder Yield | -38.98% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CS Medica has an Altman Z-Score of 0.3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.3 |
| Piotroski F-Score | n/a |